Last reviewed · How we verify

tramadol HCl ER; celecoxib — Competitive Intelligence Brief

tramadol HCl ER; celecoxib (tramadol HCl ER; celecoxib) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Opioid analgesic + selective COX-2 inhibitor (NSAID). Area: Pain Management.

phase 3 Opioid analgesic + selective COX-2 inhibitor (NSAID) Opioid receptors (μ, δ, κ); monoamine transporters (SERT, NET); COX-2 Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

tramadol HCl ER; celecoxib (tramadol HCl ER; celecoxib) — Bausch Health Americas, Inc.. This combination product uses tramadol (an opioid agonist and monoamine reuptake inhibitor) for pain relief and celecoxib (a selective COX-2 inhibitor) for anti-inflammatory effects.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
tramadol HCl ER; celecoxib TARGET tramadol HCl ER; celecoxib Bausch Health Americas, Inc. phase 3 Opioid analgesic + selective COX-2 inhibitor (NSAID) Opioid receptors (μ, δ, κ); monoamine transporters (SERT, NET); COX-2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Opioid analgesic + selective COX-2 inhibitor (NSAID) class)

  1. Bausch Health Americas, Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). tramadol HCl ER; celecoxib — Competitive Intelligence Brief. https://druglandscape.com/ci/tramadol-hcl-er-celecoxib. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: